Haptoglobin 2-2 Genotype is Associated with More Advanced Disease in Subjects with Non-Alcoholic Steatohepatitis: A Retrospective Study
Authors:
- the Chinese NAFLD Clinical Research Network (CNAFLD CRN)TCthe Chinese NAFLD Clinical Research Network (CNAFLD CRN)
- Jingxin ZhouJZJingxin Zhou
- Wenjun YangWYWenjun Yang
- Shufei ZangSZShufei Zang
- Junping ShiJSJunping Shi
- 28 February 2019
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 36 (4) , 880-895
Abstract
Haptoglobin (Hp) genotypes were reported as an independent risk factor for metabolic diseases. This study aimed to investigate the association between Hp gene polymorphism and the severity of nonalcoholic fatty liver disease (NAFLD).Keywords
This publication has 32 references indexed in Scilit:
- VPO1 Mediates ApoE Oxidation and Impairs the Clearance of Plasma LipidsPLOS ONE, 2013
- Haptoglobin 2-2 Genotype Is Associated with Increased Risk of Type 2 Diabetes Mellitus in Northern ChineseGenetic Testing and Molecular Biomarkers, 2012
- Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010Journal of Digestive Diseases, 2010
- Vitamin E Reduces Cardiovascular Disease in Individuals with Diabetes Mellitus and the Haptoglobin 2-2 GenotypePharmacogenomics, 2010
- Haptoglobin Genotype and Renal Function Decline in Type 1 DiabetesDiabetes, 2009
- Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal FluidJournal of Neurochemistry, 2009
- Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial designContemporary Clinical Trials, 2009
- Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 GenotypeDiabetes, 2008
- Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 GenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005